DIAPH2 _CESC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS20000106
Fusion event
HPV-DIAPH2 integration
Validated
Yes
Detection method
PCR and Sanger sequencing
Data source
Curated
Sample type
Disease
Cervical carcinoma (CC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HPV
Subtype
HPV16
Reference genome
Region type
E1
Start
1356
Integrated sequence
AATGAGTATGAGTCAATGGATAAAATATAGATGTGATAGGGTAGATGATGGAGGTGATTGGAAGCAAATTGTTATGTTTTTAAGGTATCAAGGTGTAGAG| |TTTATGTCATTTTTAACTGCATTAAAAAGATTTTTGCAAGGCATACCTAAAAAAAATTGCATATTACTATATGGTGCAGCTAACACAGGTAAATCATTAT
Host Sequence
Chromosome
chrX
Cytoband
q21.33
Reference genome
End
96471972/97216973 (Hg38)
Location type
Intronic
Target gene
Nearest miRNA
hsa-let-7f-2/Upstream/2153747; hsa-mir-105-1/Downstream/9422841;
Upstream sequence
GAGTAATATTTAGATGGTAACCCCTGCATGATCCATCCACAGGAATTCATTTACTTCTCTTTCTTGCACCATTCAGGCAGCAGTGAAACCTTTCTCTACA
Downstream sequence
TTTCTGTCACATAGTAAACACTTAGTACTATGTATGGAATTGAATTTAATAATATTAATTGGTTTAGCATGAAAAAAATTATGCTATAGTGTGAGTTAAA
Reference
Liu, Y., et al. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget,2016, 7(5): 5852-5864.
Curate